Clinical Trials Browser

Phase 4 × OTHER × tislelizumab × Clear all

NCT06951841 2025-04-30

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Phase 4 Not yet recruiting

Small Cell Lung Carcinoma

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence

NCT06357598 2024-04-10

PILOT

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05603065 2023-06-29

TINES

Phase 4 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05861635 2023-05-17

The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Phase 4 Unknown

Breast Neoplasms

NCT05580354 2022-10-14

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Phase 4 Unknown

Non-Muscle Invasive Bladder Neoplasms